9 METERS BIOPHARMA INC (NMTR) Stock Analyst Ratings
USA - NASDAQ:NMTR - US6544052086 - Common Stock
0.0722 USD
-0.05 (-42.97%)
0.093 USD
+0.02 (+28.81%)
ChartMill assigns a Buy % Consensus number of 80% to NMTR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.58. This target is 14557.2% above the current price.
NMTR was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NMTR.
In the previous month the buy percentage consensus was at a similar level.
NMTR was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-05-18 | Citigroup | Maintains | Neutral -> Neutral |
| 2023-03-20 | Truist Securities | Downgrade | Buy -> Hold |
| 2023-02-13 | Citigroup | Initiate | Neutral |
| 2022-11-10 | BMO Capital | Maintains | Outperform |
| 2022-09-27 | Oppenheimer | Maintains | Outperform |
| 2022-07-01 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-06-22 | BMO Capital | Maintains | Outperform |
| 2022-06-22 | Truist Securities | Maintains | Buy |
| 2021-07-08 | BMO Capital | Initiate | Outperform |
| 2021-06-04 | Citigroup | Initiate | Buy |
9 METERS BIOPHARMA INC / NMTR FAQ
What is the average price target for 9 METERS BIOPHARMA INC (NMTR) stock?
11 analysts have analysed NMTR and the average price target is 10.58 USD. This implies a price increase of 14557.2% is expected in the next year compared to the current price of 0.0722.
How do analysts rate 9 METERS BIOPHARMA INC (NMTR)?
The consensus rating for 9 METERS BIOPHARMA INC (NMTR) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for NMTR stock?
The number of analysts covering 9 METERS BIOPHARMA INC (NMTR) is 11.